Helvetic BioPharma is an innovative Swiss biopharmaceutical company that specializes in the manufacturing of biosimilar recombinant proteins, synthetic peptides, and monoclonal antibodies for therapeutic use. The company operates in various therapeutic areas, including oncology, hematology, immuno-modulation, and auto-immune diseases. Helvetic BioPharma is certified by SwissMedic and offers services as a contract manufacturing organisation (CMO), supported by two independent and segregated production lines dedicated to the manufacture of recombinant therapeutic proteins from both mammalian and bacterial cell sources.

Services include:
- Biologics
- Contract manufacturing of therapeutic proteins
- Production of biosimilar recombinant proteins
- Development of synthetic peptides
- Manufacturing of monoclonal antibodies

Helvetic BioPharma is committed to delivering high-quality biopharmaceutical products and services to the pharmaceutical industry. For more information, please visit helveticbio.com.